TBI(TBI)
TBI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.71B | $1.78B |
| Low | $1.71B | $1.78B |
| High | $1.71B | $1.78B |
| EBITDA Avg | $31M | $32M |
| Low | $31M | $32M |
| High | $31M | $32M |
| EBIT Avg | $3M | $3M |
| Low | $3M | $3M |
| High | $3M | $3M |
| Net Income Avg | $-7M | $19M |
| Low | $-7M | $19M |
| High | $-7M | $19M |
| EPS Avg | $-0.24 | $0.62 |
| Low | $-0.24 | $0.62 |
| High | $-0.24 | $0.62 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $454M | $439M | $423M | $440M | $462M | $455M |
| Low | $454M | $439M | $423M | $440M | $462M | $455M |
| High | $454M | $439M | $423M | $440M | $462M | $455M |
| EBITDA Avg | $8M | $8M | $8M | $8M | $8M | $8M |
| Low | $8M | $8M | $8M | $8M | $8M | $8M |
| High | $8M | $8M | $8M | $8M | $8M | $8M |
| EBIT Avg | $876,819 | $847,137 | $815,745 | $849,408 | $892,051 | $878,247 |
| Low | $876,819 | $847,137 | $815,745 | $849,408 | $892,051 | $878,247 |
| High | $876,819 | $847,137 | $815,745 | $849,408 | $892,051 | $878,247 |
| Net Income Avg | $5M | $4M | $-1M | $7M | $10M | $7M |
| Low | $5M | $4M | $-1M | $7M | $10M | $7M |
| High | $5M | $4M | $-1M | $7M | $10M | $7M |
| EPS Avg | $0.17 | $0.12 | $-0.04 | $0.22 | $0.34 | $0.24 |
| Low | $0.17 | $0.12 | $-0.04 | $0.22 | $0.34 | $0.24 |
| High | $0.17 | $0.12 | $-0.04 | $0.22 | $0.34 | $0.24 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |